SenzaGen: The beginning of the OECD effect - Redeye

Redeye endorses SenzaGen’s new GARDskin order of SEK1m from a new customer within the chemical industry. In our view, the order is a result of the OECD validation for GARDskin that SenzaGen received during the summer of 2022. We believe this is the start of increased demand for the testing method and expect similar orders as we advance. We reiterate our base case of SEK21.

Länk till analysen i sin helhet: https://www.redeye.se/research/883695/senzagen-the-beginning-of-the-oecd-effect?utm_source=finwire&utm_medium=RSS